Search

everythinglearnresearchcommunity

for

Search:↓

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

JAK inhibitors partially restore scalp bacteria balance in alopecia areata patients.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

New treatments focusing on immune pathways show promise for stubborn hair loss.

People with autism are more likely to develop alopecia areata than those without autism.

IL-17 is a key target for treating inflammatory skin diseases, especially psoriasis.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Gasdermin A3 causes hair follicle stem cells to activate too early, leading to hair loss.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.

No high-certainty evidence supports any specific acne treatment.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.